Association between serum YKL-40 levels and endothelial function in hypertensive patients

Chinese Journal of Cardiology

Volumn 41, Issue 2, 2013, Pages 121-125

  Diao, Ying Ying ^a   Lü, Qian Zhou ^a   Yang, Chang Sheng ^b   Wei, Duo ^a  

^a ZHONGSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

^b NONE

Author keywords

Endothelium, vascular; Hypertension; YKL 40 (human cartilage glycoprotein 39)

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; ENDOTHELIN 1; MEMBRANE PROTEIN; NITRIC OXIDE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; URIC ACID; YKL 40 PROTEIN;

ADULT; AGED; ARTICLE; BLOOD VESSEL PARAMETERS; BODY MASS; CELL FUNCTION; COHORT ANALYSIS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ENDOTHELIUM FUNCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ESSENTIAL HYPERTENSION; FEMALE; FLOW MEDIATED DILATATION; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; SYSTOLIC BLOOD PRESSURE;

ADIPOKINES; ADULT; AGED; CASE-CONTROL STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPERTENSION; LECTINS; MALE; MIDDLE AGED;

EID: 84875776884     PISSN: 02533758     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0253-3758.2013.02.009     Document Type: Article

References (20)

1. 2010, 31:203-205.
2. 2005, 24:499-501.
3. Michelsen A E, Rathcke C N, Skjelland M, et al. Increased YKL-40 expression in patients with carotid atherosclerosis. Inflamm Res, 2011, 60:281-595.
4. Bilim O, Takeishi Y, Kitahara T, et al. Serum YKL-40 predicts adverse clinical outcomes in patients with chronic heart failure. J Card Fail, 2010, 16:873-879.
5. Yasuda T, Kaneto H, Katakami N, et al. YKL-40, a new biomarker of endothelial dysfunction, is independently associated with albuminuria in type 2 diabetic patients. Diabetes Res Clin Pract, 2011, 91:E50-E52.
6. Mathiasen A B, Henningsen K, Harutyunyan M J, et al. YKL-40: a new biomarker in cardiovascular disease?. Biomark Med, 2010, 4:591-600.
7. Rathcke C N, Vestergaard H. YKL-40-an emerging biomarker in cardiovascular disease and diabetes. Cardiovasc Diabetol, 2009, 8: 61.
8. Corretti M C, Anderson T J, Benjamin E J, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery. A report of the international brachial artery reactivity task force. J Am Coll Cardiol, 2002, 39: 257-265.
9. 2004, 12: 156-161.
10. Johansen J S. Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer. Dan Med Bull, 2006, 53:172-209.
11. Rathcke C N, Vestergaard H. YKL-40, a new inflammatory marker with relation to insulin resistance and with a role in endothelial dysfunction and atherosclerosis. Inflamm Res, 2006, 55:221-227.
12. Rathcke C N, Persson F, Tarnow L, et al. YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with type 1 diabetes and increases with levels of albuminuria. Dianetes Care, 2009, 32:323-328.
13. Masajtis-Zagajewska A, Majer J, Nowicki M, et al. Effect of moxonidine and amlodipine on serum YKL-40, plasma lipids and insulin sensitivity in insulin-resistant hypertensive patients-a randomized, crossover trial. Hypertens Res, 2010, 33:348-353.
14. 2012, 36: 118-122.
15. Mygind N D, Harutyunyan M J, Mathiasen A B, et al. The influence of statin treatment on the inflammatory biomarkers YKL-40 and HsCRP in patients with stable coronary artery disease. Inflamm Res, 2011, 60:281-287.
16. Nielsen A R, Plomgaard P, Krabbe K S, et al. IL-6, but not TNF-alpha, increases plasma YKL-40 in human subjects. Cytokine, 2011, 55:152-155.
17. Nielsen A R, Erikstrup C, Johansen J S, et al. Plasma YKL-40-a BMI-independent marker of type 2 diabetes. Diabetes, 2008, 511:S312.
18. Mathiasen A B, Harutyunyan M J, Jørgensen E, et al. Plasma YKL-40 in relation to the degree of coronary artery disease in patients with stable ischemic heart disease. Scand J Clin Lab Invest, 2011, 71:439-447.
19. Malinda K M, Ponce L, Kleinman H K, et al. Gp38k, a protein synthesized by vascular smooth muscle cells, stimulates directional migration of human umbilical vein endothelial cells. Exp Cell Res, 1999, 250:168-173.
20. Shao R, Hamel K, Petersen L, et al. YKL-40, a secreted glycoprotein, promotes tumor angiogenesis. Oncogene, 2009, 28: 4456-4468.